The Clorox Company (NYSE:CLX) Shares Sold by Tsfg LLC

Tsfg LLC lowered its stake in shares of The Clorox Company (NYSE:CLXFree Report) by 18.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 752 shares of the company’s stock after selling 168 shares during the period. Tsfg LLC’s holdings in Clorox were worth $115,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Point72 Asset Management L.P. acquired a new stake in Clorox during the fourth quarter worth $144,844,000. Norges Bank acquired a new stake in shares of Clorox during the fourth quarter valued at about $128,382,000. Parsifal Capital Management LP acquired a new stake in shares of Clorox during the fourth quarter valued at about $128,245,000. Confluence Investment Management LLC acquired a new position in shares of Clorox in the 1st quarter worth approximately $135,630,000. Finally, International Assets Investment Management LLC boosted its position in shares of Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after purchasing an additional 481,725 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

Shares of NYSE CLX opened at $136.48 on Friday. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The stock has a market cap of $16.95 billion, a P/E ratio of 70.72, a P/E/G ratio of 2.19 and a beta of 0.39. The stock has a 50 day moving average of $136.95 and a two-hundred day moving average of $143.79. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.14.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the prior year, the business earned $1.51 EPS. Clorox’s quarterly revenue was down 5.3% compared to the same quarter last year. On average, research analysts forecast that The Clorox Company will post 5.91 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of research analyst reports. The Goldman Sachs Group began coverage on Clorox in a research report on Friday, March 1st. They issued a “sell” rating and a $140.00 target price on the stock. Morgan Stanley reissued an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft cut their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research note on Wednesday, April 17th. Evercore ISI dropped their price target on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday, May 1st. Finally, Barclays decreased their target price on Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. Five investment analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $145.33.

View Our Latest Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.